| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.6829 | 30 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.0578 | 27 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.1795 | 38 |
| GSM780719 | Untreated after 4 days (C1_2) | 39.2818 | 5 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.4367 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.5771 | 30 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.1939 | 42 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.9854 | 22 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.3528 | 38 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.8886 | 27 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.5916 | 43 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.9736 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.5663 | 15 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.811 | 31 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.8103 | 31 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.2847 | 19 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.4508 | 20 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.4847 | 43 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.142 | 18 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.0174 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.6701 | 47 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.4084 | 24 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.6672 | 30 |